Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,328,009
+$849,884 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#2,721
of 4,676 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prairie Wealth Advisors, Inc. holds $8,080,397 across 9 Drug Manufacturers - General names. JNJ ranks #3 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
0 | $2,745,919 | |
| 2 | AMGN |
Amgen Inc
|
0 | $1,629,721 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
0 | $1,328,009 | |
| 4 | ABBV |
AbbVie Inc.
|
0 | $909,175 | |
| 5 | NVS |
Novartis AG
|
0 | $399,636 | |
| 6 | GSK |
GSK plc
|
0 | $311,818 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
0 | $272,389 | |
| 8 | MRK |
Merck & Co., Inc.
|
0 | $269,979 |
All Filings in JNJ
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,328,009 | 0 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $478,125 | 0 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $507,234 | 0 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $454,464 | 2,451 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $402,649 | 2,636 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $442,958 | 2,671 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $442,681 | 3,061 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $482,452 | 2,977 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $427,518 | 2,925 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $523,134 | 3,307 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||